Literature DB >> 26897170

PAR-1 mediated apoptosis of breast cancer cells by V. cholerae hemagglutinin protease.

Tanusree Ray1, Amit Pal2.   

Abstract

Bacterial toxins have emerged as promising agents in cancer treatment strategy. Hemagglutinin (HAP) protease secreted by Vibrio cholerae induced apoptosis in breast cancer cells and regresses tumor growth in mice model. The success of novel cancer therapies depends on their selectivity for cancer cells with limited toxicity for normal tissues. Increased expression of Protease Activated Receptor-1 (PAR-1) has been reported in different malignant cells. In this study we report that HAP induced activation and over expression of PAR-1 in breast cancer cells (EAC). Immunoprecipitation studies have shown that HAP specifically binds with PAR-1. HAP mediated activation of PAR-1 caused nuclear translocation of p50-p65 and the phosphorylation of p38 which triggered the activation of NFκB and MAP kinase signaling pathways. These signaling pathways enhanced the cellular ROS level in malignant cells that induced the intrinsic pathway of cell apoptosis. PAR-1 mediated apoptosis by HAP of malignant breast cells without effecting normal healthy cells in the same environment makes it a good therapeutic agent for treatment of cancer.

Entities:  

Keywords:  Apoptosis; HAP; MAP kinase; NFκB; PAR-1

Mesh:

Substances:

Year:  2016        PMID: 26897170     DOI: 10.1007/s10495-016-1229-2

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  6 in total

1.  Characterization of Platelet Function-Related Gene Predicting Survival and Immunotherapy Efficacy in Gastric Cancer.

Authors:  Yan Xia; Xin Lin; Yangyang Cheng; Huimin Xu; Jingya Zeng; Wanlin Xie; Mingzhu Wang; Yihua Sun
Journal:  Front Genet       Date:  2022-06-28       Impact factor: 4.772

2.  Cell type-specific mechanisms coupling protease-activated receptor-1 to infectious colitis pathogenesis.

Authors:  Alexander A Boucher; Leah Rosenfeldt; Duaa Mureb; Jessica Shafer; Bal Krishan Sharma; Adam Lane; Rebecca R Crowther; Melanie C McKell; Jordan Whitt; Theresa Alenghat; Joseph Qualls; Silvio Antoniak; Nigel Mackman; Matthew J Flick; Kris A Steinbrecher; Joseph S Palumbo
Journal:  J Thromb Haemost       Date:  2019-10-11       Impact factor: 5.824

3.  Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer.

Authors:  Huijuan Liu; Honglian Tao; Hongqi Wang; Yuyan Yang; Ru Yang; Xintong Dai; Xiujuan Ding; Haidong Wu; Shuang Chen; Tao Sun
Journal:  Front Oncol       Date:  2021-02-11       Impact factor: 6.244

4.  Heterogeneity induced GZMA-F2R communication inefficient impairs antitumor immunotherapy of PD-1 mAb through JAK2/STAT1 signal suppression in hepatocellular carcinoma.

Authors:  Yuxue Gao; Qingguo Xu; Xinqiang Li; Yuan Guo; Bowen Zhang; Yan Jin; Cunle Zhu; Yuntai Shen; Pengxiang Yang; Ying Shi; Rifeng Jin; Daojie Liu; Yabo Ouyang; Xiaoni Liu; Wenjing Wang; Dexi Chen; Tongwang Yang
Journal:  Cell Death Dis       Date:  2022-03-07       Impact factor: 9.685

5.  Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles.

Authors:  Svitlana Vdovikova; Siv Gilfillan; Shixiong Wang; Mitesh Dongre; Sun Nyunt Wai; Antoni Hurtado
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

6.  Bioinformatic analysis of the expression and prognosis of ZNF589 in human breast cancer.

Authors:  Jun Fan; Zhe Zhang; Dongjiao Chen; Hongqiang Chen; Wenbo Yuan; Lu Zhou; Jing Xu; Wenbin Liu; Yan Xu
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.